本文提到的股票： 拜玛林制药(BMRN)
基于24个网页-相关网页
Genzyme splits revenue from Aldurazyme with BioMarin Pharmaceutical (nasdaq: BMRN - news - people ).
FORBES: Can Genzyme Defy Skeptics Again?
The U.S. Food and Drug Administration yesterday approved BioMarin's (nasdaq: BMRN - news - people ) first drug, a treatment for a rare genetic disease.
FORBES: BioMarin Gets Ready To Bloom
Biomarin (nasdaq: BMRN - news - people ) and Alexion (nasdaq: ALXN - news - people ) have launched drugs for orphan diseases.
FORBES: Genzyme Eyes Isis Drug
应用推荐
模块上移
模块下移
不移动